During Theiler's murine encephalomyelitis virus (TMEV)
infection of macrophages, it is thought that high
interleukin-6 (IL-6) levels contribute to the
demyelinating disease found in chronically infected SJL/J mice but absent in B10.S mice capable of clearing the
infection. Therefore,
IL-6 expression was measured in TMEV-susceptible SJL/J and TMEV-resistant B10.S macrophages during their
infection with TMEV DA strain or responses to
lipopolysaccharide (LPS) or
poly(I · C). Unexpectedly,
IL-6 production was greater in B10.S macrophages than SJL/J macrophages during the first 24 h after stimulation with TMEV, LPS, or
poly(I · C). Further experiments showed that in B10.S, SJL/J, and RAW264.7 macrophage cells,
IL-6 expression was dependent on
extracellular signal-regulated kinase (ERK)
mitogen-activated protein kinase (MAPK) and enhanced by exogenous
IL-12. In SJL/J and RAW264.7 macrophages, exogenous
IL-6 resulted in decreased TMEV replication, earlier activation of STAT1 and STAT3, production of
nitric oxide, and earlier upregulation of several
antiviral genes downstream of STAT1. However, neither inhibition of IL-6-induced
nitric oxide nor knockdown of STAT1 diminished the early
antiviral effect of exogenous
IL-6. In addition, neutralization of endogenous
IL-6 from SJL/J macrophages with Fab
antibodies did not exacerbate early TMEV
infection. Therefore, endogenous
IL-6 expression after TMEV
infection is dependent on ERK MAPK, enhanced by
IL-12, but too slow to decrease viral replication during early
infection. In contrast, exogenous
IL-6 enhances macrophage control of TMEV
infection through preemptive
antiviral nitric oxide production and
antiviral STAT1 activation. These results indicate that immediate-early production of
IL-6 could protect macrophages from TMEV
infection.